Florida Oncology Symposium:

2nd ANNUAL 

Florida Oncology Symposium: 

Clinical Pathways to Personalized Medicine 

May 5 – 7, 2011 

The Ritz-Carlton Hotel 

Naples, Florida



May 5 – 7, 2011 The Ritz-Carlton Hotel | Naples, Florida 

COURSE DESCRIPTION 

Our second symposium offers learning opportunities and 

networking for those clinicians wanting to learn more about 

the latest clinical research applications to patient care in the 

diagnosis and management of various cancers: Hematology, 

Genitourinary Cancers, Melanoma, HPV and Sarcoma. 

In addition, an update on the progress of Moffitt’s newly 

developed clinical pathways will be offered as a concurrent 

breakout session. These pathways have been developed to 

assist and to improve clinical outcomes in these disease sites: 

breast, prostate, lung, acute leukemia, sarcoma and pancreas. 

The objective is to catalyze clinician consensus and to reduce 

clinician variation toward the best possible outcome given 

a patient’s unique clinical factors, genetics, and personal 

preferences. These pathways are primarily designed to support 

the administration of therapies proven to optimize efficacy and 

reduce toxicity, and secondarily to manage cost when prudent 

choices between clinically similar alternatives can drive more 

affordable, quality care. 

We are proud to share 

the early progress 

toward clinical pathways 

development with the 

conference participants 

to achieve an even 

better product by 

incorporating related 

feedback and 

collaboration. 

TARGET AUDIENCE 

This educational activity 

is planned to meet the 

educational needs of 

clinical and surgical oncologists in both academia and private 

practice. Primary care physicians and nurses in oncology will 

benefit from the presentations and small group discussions in 

the latest cancer treatment modalities. 

PROGRAM OBJECTIVES 

Upon completion of this program, participants should 

be able to: 

• Discuss circulating tumor cells and how they can serve 

as a new platform to provide personalized medicine. 

• To tailor therapies for chronic leukemias. 

• Understand how HPV vaccination can be used to 

prevent different cancers in both women and men. 

• Assess the current role of robotic cystectomy in the 

management of localized bladder cancer. 

• Evaluate management options for prostate, bladder 

and kidney cancer. 

• Describe new drugs and targets that are important 

in early phase clinical trials. 

• Discuss the diagnosis and treatment of GIST, 

soft tissue and bone sarcomas. 

• Recognize how clinical pathways use a patient’s genetic 

signature to formulate personalized therapy. 

• Recognize the benefits of immunotherapy for 

melanoma and hematologic malignancies. 

ACCREDITATION 

Physicians USF Health is accredited by the Accreditation 

Council for Continuing Medical Education to provide continuing 

medical education for physicians. 

USF Health designates this educational activity for a maximum 

of 16.25 AMA PRA Category 1 Credits . Physicians should only 

claim credit commensurate with the extent of their participation 

in the activity. 

Nurses The University of South Florida College of Nursing 

is accredited as a provider of continuing nursing education 

by the American Nurses Credentialing Center’s Commission 

on Accreditation. 

A maximum of 16.25 contact hours may be earned by 

learners who successfully complete this continuing nursing 

education activity.

AGENDA 

MAY 5, 2011 | THURSDAY 

11:00 am – 7:00 pm Registration 

12:45 – 1:00 pm Welcome and Introduction 

Daniel Sullivan, MD 

1:00 – 3:00 pm Personalized Medicine: 

New and Exciting Molecular Platforms 

Chairperson: Timothy Yeatman, MD, FACS 

• Circulating Tumor Cells as a Guide to Personalized 

Medicine in Cancer — David Nelson, PhD 

• Integrating Biomarkers into Colorectal Cancer Clinical 

Trials — Scott Kopetz, MD, PhD 

• The “Next Generation” of Translational Oncology — 

Levi Garraway, MD, PhD 

3:00 – 3:15 pm Break 

3:15 – 5:15 pm Molecular Determinants of Response 

in Clinical Oncology 

• Microarrays for Diagnosis, Prognosis and Treatment 

Planning of Breast Cancer — Stefan Glück, MD, PhD, FRCPC 

• Biomarkers That Determine Response in Multiple Myeloma 

and Non-Hodgkin’s Lymphoma — Steven Grant, MD 

• Biomarker-Driven Trials in Ovarian Cancer — 

Johnathan Lancaster, MD, PhD 

• Bio-marker Driven Trials in NSCLC — Scott Antonia, MD, PhD 

7:00 – 9:00 pm Dinner with Keynote speaker 

Molecular Signatures for Guiding Therapies of 

Non-Small Cell Lung Cancer 

David Carbone, MD, PhD 

MAY 6, 2011 | FRIDAY 

7:00 – 7:55 am Breakfast and Exhibits 

7:55 – 8:00 am Welcome and Introduction 

Alan List, MD, Course Director 

8:00 - 10:00 am SESSION 1: Hematology/Oncology 

Chairperson: Eduardo Sotomayor, MD 

• AML in the Elderly: New Therapies — Jeffrey Lancet, MD 

• Consolidation therapy in AML: Should we transplant 

everyone? — Hugo Fernandez, MD 

• Targeted Therapies for Chronic Leukemias — 

Javier Pinilla-Ibarz, MD, PhD 

• Radioimmunotherapy for Hematologic Malignancies — 

Michael Tomblyn, MD 

10:00 – 10:30 am Break and Exhibits 

10:30 – 11:30 am SESSION 2: Prevention of HPV – 

Related Cancers: Current Practice and 

Future Horizons 

Chairperson: Dana Rollison, PhD 

• Cancer Prevention through HPV Vaccination in Men 

and Women — Kevin Collins, MD 

• Cutaneous HPV and Non-Melanoma Skin Cancer — 

Dana Rollison, PhD 

11:30 am – 12:45 pm Luncheon with Keynote Speaker 

Quality, Measurement and Economics of 

Health Care Systems 

Lisa Slama, PhD 

12:45 – 2:30 pm SESSION 3: Genitourinary Cancers 

Chairperson: Julio Pow-Sang, MD 

• Active Surveillance and Surgical Options for Localized 

Prostate Cancer — Julio Pow-Sang, MD 

• Radiation Therapy Options for Localized Prostate Cancer - 

Richard Wilder, MD 

(FRIDAY CONTINUED) 

• Treatment Options for Hormone Refractory Prostate 

Cancer — Jingsong Zhang, MD, PhD 

• Management Options for Small Renal Tumors — 

Philippe Spiess, MD 

• Emerging Role of Robotic Cystectomy in the Management 

of Invasive Bladder Cancer — Wade Sexton, MD 

2:30 - 4:30 pm SESSION 4: Moffitt Pathways 

Chairperson: Robert Wenham, MD 

2:30 – 3:00 pm Pathways to Improving Clinical Outcomes 

Mark Schippits, MD 

3:00 - 3:30 pm Break and Exhibits 

3:30 – 4:00 pm Break Out Sessions (select one) 

• Breast — Hatem Soliman, MD 

• Prostate — Mayer Fishman, MD, PhD and J. Zhang, MD, PhD 

• Lung — Mary Pinder, MD 

• Acute Leukemia — Jeffrey Lancet, MD 

• Sarcoma — Damon Reed, MD 

• Pancreatic — Gregory Springett, MD, PhD 

4:00 – 4:30 pm Break Out Sessions Repeated (select one) 

• Breast — Hatem Soliman, MD 

• Prostate — Mayer Fishman, MD, PhD and J. Zhang, MD, PhD 

• Lung — Mary Pinder, MD 

• Acute Leukemia — Jeffrey Lancet, MD 

• Sarcoma — Damon Reed, MD 

• Pancreatic — Gregory Springett, MD, PhD 

Evening on Your Own 

MAY 7, 2011 | SATURDAY 

7:00 – 8:00 am Breakfast 

8:00 – 9:30 am SESSION 5: Advances in the Treatment of 

Metastatic Melanoma 

Chairperson: Jeffrey Weber, MD, PhD 

• INTRODUCTION: Melanoma: Poster Child for Novel and 

Targeted Therapies — Jeffrey Weber, MD, PhD 

• Regional Treatment for Melanoma: Liver or Limb? — 

Jonathan Zager, MD 

• Targeted Therapy for Melanoma is Here At Last — 

Ragini Kudchadkar, MD 

• Novel Immunotherapies for Melanoma Prolong Survival — 

Jeffrey Weber, MD, PhD 

9:30 – 10:00 am Break and Exhibits 

10:00 – 11:30 am SESSION 6: Advances in Drug Development 

Chairperson: Saïd Sebti, MD, PhD 

• Targeting the Akt Pathway: From Basic Science to 

Hypothesis-driven Clinical Trials — Saïd Sebti, MD, PhD 

• Disruptors of the Binding of Raf1 Kinase to the 

Tumor Suppressor Rb as Novel Anticancer Drugs — 

Kumar Chellappan, MD 

• Targeting Shp2 Protein Phosphatase for Drug Discovery — 

Jerry Wu, MD 

11:30 am – 1:00 pm Lunch with Guest Speaker 

1:00 – 2:30 pm SESSION 7: Sarcoma 

Chairperson: Douglas Letson, MD 

• GIST — Updates and Future Direction — Rick Gonzalez, MD 

• Bone Sarcomas: What Have we Learned and Where are 

the Opportunities for Improvement? — Damon Reed, MD 

• Soft Tissue Sarcoma: Breaking Tradition — 

Anthony Conley, MD 

2:30 pm Closing Remarks/Conference Adjourns

Name ____________________________________________________________ 

Degree/Credentials ________________________________________________ 

Date of Birth (MM/DD) _________________ Specialty ________________ 

License #__________________________________________________________ 

Organization ______________________________________________________ 

Address __________________________________________________________ 

City________________________________ State_________ ZIP __________ 

Phone________________________ Fax ________________________________ 

E-mail ____________________________________________________________ 

Attendance Thursday keynote dinner ❏ Yes ❏ No 

Attendance Saturday night dinner ❏ Yes ❏ No 

❏ Complimentary nurse registration accompanying physician 

Name ____________________________________________________________ 

License #__________________________________________________________ 

E-mail ____________________________________________________________ 

FEES 

REGISTRATION FORM 

FLORIDA ONCOLOGY SYMPOSIUM 

May 5 – 7, 2011 

The Ritz-Carlton Hotel | Naples, Florida 

REGISTRATION FEE INCLUDES: 

Conference materials and all meal functions during conference. 

Attendance Thursday keynote dinner ❏ Yes ❏ No 

Attendance Saturday night dinner ❏ Yes ❏ No 

Please place a check mark next to your registration type. 

❏ Physician ..............................................................................................$225.00 

❏ Physician Assistant ..................................................................$1 75.00 

❏ Nurse ............................................................................................$1 75.00 

❏ Other Health Care Professional ..............................................$150.00 

Dinner Guests 

❏ Thursday night dinner ................................................................$40.00 

# of guests _____ 

❏ Saturday night reception and dinner ....................................$75.00 

# of guests _____ 

❏ Children (7-14) Saturday dinner ............................................$25.00 

# of children _____ 

TOTAL AMOUNT $______________ 

On-line registration deadline May 2, 2011. 

On-site registration will be available. 

PAYMENT METHOD 

❏ Check (payable to Moffitt Cancer Center) 

❏ MasterCard ❏ Visa ❏ American Express ❏ Discover 

Amount $______________ 

Credit Card # ______________________________________________________ 

Expiration Date ____________________________________________________ 

Cardholder Name __________________________________________________ 

Signature ________________________________________________________ 

REGISTRATION OPTIONS 

• On-line at www.moffitt.org/FOS2011 

• Paper Registration, please mail along with payment to: 

Moffitt Cancer Center 

MBC-CONFPLAN 

12902 Magnolia Drive 

Tampa, FL 33612-9497 

For further information, contact Melissa Pearson at 813-745-1247 

or Melissa.Pearson@moffitt.org 

REFUND POLICY: An administrative fee of $50.00 will be assessed for cancellations 

received on or before April 22, 2011 and no refunds will be issued after this date. 

Events, activities, programs and facilities of the University of South Florida are available 

to all without regard to race, color, marital status, gender, sexual orientation, religion, 

national origin, disability, age, Vietnam or disabled veteran status as provided by law 

and in accordance with the university’s respect for personal dignity. 

USF HPCC is an Equal Opportunity/Equal Access Institution. For disability accommodations 

contact USF HPCC at 813-974-7420, a minimum of five (5) working days in advance. 

Program # CH 2011401/1160

FACULTY 

COURSE DIRECTOR 

Alan List, MD 

Professor of Medicine & Oncologic Sciences 

Executive Vice President & Physician-in-Chief 

The Frank & Carol Morsani Endowed Chair 

Moffitt Cancer Center 

Tampa, Florida 

Guest Faculty 

David Carbone, MD, PhD 

Professor of Medicine and Cancer Biology 

Vanderbilt University Cancer Center 

Nashville, Tennessee 

Kevin Collins, MD 

Director, Clinical Services 

Student Health 

Florida Gulf Coast University 

Fort Myers, Florida 

Levi Garraway, MD, PhD 

Assistant Professor 

Department of Medical Oncology 

Harvard Medical School 

Dana-Farber Cancer Institute 

Boston, Massachusetts 

Stefan Glück, MD, PhD, FRCPC 

Sylvester Professor, Department of Medicine 

University of Miami 

Leonard M. Miller School of Medicine 

Assistant Director, Associate Chief 

Division of Hematology/Oncology 

Sylvester Comprehensive Cancer Center 

Miami, Florida 

Steven Grant, MD 

Associate Director, Translational Research 

Co-Director, Cancer Cell Biology Program 

Virginia Commonwealth University 

Massey Cancer Center 

Richmond, Virginia 

Scott Kopetz, MD, PhD 

Assistant Professor 

GI Medical Oncology 

University of Texas 

M.D. Anderson Cancer Center 

Houston, Texas 

David Nelson, PhD 

President and CEO 

Epic Sciences 

San Diego, California 

Lisa Slama, PhD 

Associate Vice President 

Sg2 

Skokie, Illinois 

ACCOMMODATIONS 

THE RITZ-CARLTON NAPLES 

280 Vanderbilt Beach Road 

Naples, Florida 34108 

239-598-3300 

www.ritzcarlton.com 

USF Health Faculty 

at Moffitt Cancer Center 

Scott Antonia, MD, PhD 

Professor of Oncologic Sciences 

Chairman, Thoracic Oncology Department 

Co-Leader, Immunology Program 

Srikumar Chellappan, PhD 

Professor of Molecular Medicine & Oncologic Sciences 

Professor & Chair, Department of Tumor Biology 

Scientific Director, National Functional Genomics Center 

Anthony Conley, MD 

Assistant Professor of Oncologic Sciences 

Sarcoma Program 

Hugo Fernandez, MD 


Associate Chair & Clinical Director 

Department of Blood & Marrow Transplantation 

Mayer Fishman, MD, PhD 

Associate Professor of Medicine & Oncologic Sciences 

Genitourinary Oncology 

Experimental Therapeutics Program 

Ricardo Gonzalez, MD 


Surgical Oncologist, Sarcoma Program 

& Cutaneous Oncology 

Ragini Kudchadkar, MD 

Assistant Professor of Medicine & Oncologic Sciences 

Cutaneous Oncology Program 

Johnathan Lancaster, MD, PhD 

Associate Professor, Department of Oncologic Sciences 

Chair, Department of Women’s Oncology 

Director, Center for Women's Oncology 

Jeffrey Lancet, MD 

Associate Professor of Medicine & Oncologic Sciences 

Section Head, Leukemia 

Department of Malignant Hematology 

Douglas Letson, MD 

Professor of Radiology, Orthopaedic Oncology & Surgery 

Division Chair, Sarcoma Program 

Mary Pinder-Schneck, MD 


Medical Oncology 

Thoracic Oncology Program 

Javier Pinilla-Ibarz, MD, PhD 



Julio Pow-Sang, MD 

Professor of Surgery & Oncologic Sciences 

Chief, Surgery Services 

Director, Robotics Program 

Department of GU Oncology 

Damon Reed, MD 


Medical Oncologist, Sarcoma Program 

Dana Rollison, PhD 

VP/Chief, of Health Informatics 

Associate Professor of Oncologic Sciences 

Scientific Director, Moffitt Cancer Registry 

Co-Scientific Director, Moffitt Tissue Core 

Mark Schippits, MD 

Director, Clinical Informatics Program 

Saïd Sebti, PhD 


Garcia Endowed Professor & Chair 

Director, Drug Discovery Comprehensive 

Research Center 

Department of Drug Discovery 

Wade Sexton, MD 

Associate Professor of Oncologic Sciences 

Genitourinary Program 

Fellowship Director 

Hatem Soliman, MD 


Comprehensive Breast Program 

Department of Women’s Oncology 

Eduardo Sotomayor, MD 


Susan and John Sykes Endowed Chair in Malignant 

Hematology 


Phillip Spiess, MD 


Genitourinary Oncology & Urology 

Gregory Springett, MD, PhD 


Department of Gastrointestinal Oncology 

Section of Pancreatic Oncology 

Experimental Therapeutics & Drug Discovery Department 

Daniel Sullivan, MD 

Professor of Medicine, 

Molecular Medicine& Oncologic Sciences 

Executive Vice President & Associate 

Center Director for Clinical Investigations 

Leader, Phase I Program 

Blood & Marrow Transplantation Department 

Michael Tomblyn, MD, MS 

Assistant Professor of Medicine & Oncologic Sciences, 

Department of Radiation Oncology 

Jeffrey Weber, MD, PhD 


Director, Donald A. Adam Comprehensive 

Melanoma Research Center 

H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE, AN NCI COMPREHENSIVE CANCER CENTER - TAMPA, FL. 1-888-MOFFITT 

© 2011 H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. All rights reserved. 

Robert Wenham, MD, MS, FACOG 


Clinical Director, Gynecologic Oncology Medical Director, 

Moffitt Clinical Research Network 

Principal Investigator, 

Total Cancer Care Department of Women's Oncology 

Richard Wilder, MD, MBA, MS 

Associate Professor of Radiology & Oncologic Sciences 

Radiation Oncology/Genitourinary Oncology 

Department of Radiation Oncology 

Jie Wu, PhD 


Department of Molecular Oncology 

Timothy Yeatman, MD, FACS 

Professor of Surgery & Oncologic Sciences 

Executive Vice President and 

Founding Chief Scientific Officer 

Moffitt Medical Group 

Jonathan Zager, MD, FACS 

Assistant Professor of Surgery & Oncologic Sciences 

Cutaneous Oncology Program 

Sarcoma Program 

Jingsong Zhang, MD, PhD 


Genitourinary Program 

Experimental Therapeutics Program 

FACULTY DISCLOSURE | USF Health adheres to the 

ACCME Standards regarding commercial support of 

continuing medical education. It is the policy of USF 

Health and Moffitt Cancer Center that the faculty and 

planning committee disclose real or apparent conflicts 

of interest relating to the topics of this educational 

activity, that relevant conflict(s) of interest are 

resolved, and also that speakers will disclose any 

unlabeled/unapproved use of drug(s) or device(s) 

during their presentation. Detailed disclosure will be 

made in the course syllabus. 

The Ritz-Carlton, Naples offers dazzling views of the Gulf of Mexico, three miles of pristine beaches, 

world-class restaurants and impeccable service, The Ritz-Carlton in Naples, Florida, offers an 

unforgettable retreat in one of the world’s most beautiful locations. 

A block of rooms have been reserved for our conference for the special price of $209.00 single/double 

occupancy. Reserve your room by calling 1-888-856-4380 and reference the Moffitt Cancer Center 

conference or on the Reservations page of www.ritzcarlton.com by entering group code QNEQNEA. 

Reservations must be made on or before April 5, 2011. 

Check-in 4:00 pm; check-out 12 noon. Valet parking only for cost of $15 per night. 

__ 2/11

NON-PROFIT ORG 

US POSTAGE 

PAID 

TAMPA FL 

PERMIT NO 2849 

H. Lee Moffitt Cancer Center 

& Research Institute 

12902 Magnolia Drive 

Tampa, FL 33612-9416 

2nd ANNUAL 



May 5 – 7, 2011 

The Ritz-Carlton Hotel 

Naples, Florida

Florida Oncology Symposium:

Create successful ePaper yourself

Delete template?

Save as template?